Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

In a report released today, Nicole Germino from Truist Financial maintained a Buy rating on Perspective Therapeutics (CATX – Research Report). The company’s shares closed last Friday at $4.01.

Akero Therapeutics (AKRO) announced that it has commenced an underwritten public offering of $300M of shares of its common stock. All of the shares in the proposed offering are being offered by Akero.

Aileron Therapeutics pulled a hard pivot in 2023, merging with Lung Therapeutics to gain a new pipeline and investor base. | ...

"Tom has an extraordinary talent for transforming groundbreaking science into scalable biotechnology companies focused on developing entirely new ways of treating disease," said Dr. Zaks. "His ...

Novartis has reached an agreement to take control of Kate Therapeutics, a developer of gene therapies for inherited neuromuscular diseases, including Duchenne muscular dystrophy (DMD). The ...

Dan Kitwood/Getty Kate Middleton made a last-minute decision to join Prince William at a ceremony commemorating Holocaust Memorial Day for her first official appearance since announcing that she ...

Kate Beckinsale has disappeared from social media (Picture: Evan Agostini/Invision/AP) Kate Beckinsale has puzzled fans by vanishing completely from social media. The actress is famously active on ...

A Quick Take On Odyssey Therapeutics, Inc. Odyssey Therapeutics ... FMR (Fidelity), Foresite Capital, Logos Opportunities Fund and General Catalyst Partners. According to a 2024 market research ...

Kate took to her Instagram Story over the weekend, where she posted a video, showing off just some of her new house. And it seems like the perfect place for Kate to entertain — especially the ...

A chance encounter brought together writer-director Kate Beecroft and her latest subject and lead, Tabatha Zimiga. A wrong turn down an unnamed road led to years of cohabitation on Zimiga’s ...